BOIP Stock Overview

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. More details

BOIP fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	2/6
Past Performance	1/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 45.6% below our estimate of its fair value

Earnings are forecast to grow 7.58% per year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Boiron SA Competitors

Animalcare Group

AIM:ANCR

UK£165.5m

Hikma Pharmaceuticals

LSE:HIK

UK£4.6b

ECO Animal Health Group

AIM:EAH

UK£42.3m

GSK

LSE:GSK

UK£55.3b

Price History & Performance

Summary of share price highs, lows and changes for Boiron
Historical stock prices
Current Share Price	€50.60
52 Week High	€50.60
52 Week Low	€37.35
Beta	0.47
1 Month Change	0%
3 Month Change	n/a
1 Year Change	14.74%
3 Year Change	15.13%
5 Year Change	-11.23%
Change since IPO	20.68%

Recent updates

Shareholder Returns

	BOIP	GB Pharmaceuticals	GB Market
7D	0%	0.3%	3.5%
1Y	14.7%	-2.0%	10.5%

Return vs Industry: BOIP exceeded the UK Pharmaceuticals industry which returned -7.1% over the past year.

Return vs Market: BOIP exceeded the UK Market which returned -2.4% over the past year.

Price Volatility

Is BOIP's price volatile compared to industry and market?
BOIP volatility
BOIP Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.7%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	10.9%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: BOIP has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BOIP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1932	2,813	Valérie Lorentz-Poinsot	www.boiron.fr

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain.

Boiron SA Fundamentals Summary

How do Boiron's earnings and revenue compare to its market cap?
BOIP fundamental statistics
Market cap	€937.56m
Earnings (TTM)	€47.62m
Revenue (TTM)	€517.36m

19.6x

P/E Ratio

1.8x

P/S Ratio

Is BOIP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BOIP income statement (TTM)
Revenue	€517.36m
Cost of Revenue	€135.11m
Gross Profit	€382.25m
Other Expenses	€334.63m
Earnings	€47.62m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Mar 18, 2024

Earnings per share (EPS)	2.74
Gross Margin	73.88%
Net Profit Margin	9.20%
Debt/Equity Ratio	0.5%

How did BOIP perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

40%

Payout Ratio

Does BOIP pay a reliable dividends?

See BOIP dividend history and benchmarks

When do you need to buy BOIP by to receive an upcoming dividend?
Boiron dividend dates
Ex Dividend Date	Oct 18 2023
Dividend Pay Date	Oct 20 2023
Days until Ex dividend	461 days
Days until Dividend pay date	459 days

Does BOIP pay a reliable dividends?

See BOIP dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/10/04 08:24
End of Day Share Price	2023/07/07 00:00
Earnings	2023/06/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Boiron SA is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Stéphan Dubosq	Arkeon Finance
Guillaume Cuvillier	Gilbert Dupont
Stephanie Lefebvre	Gilbert Dupont